RBC Capital Remains a Hold on SAGE Therapeutics (SAGE)
RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) on January 21 and set a price target ...
RBC Capital Remains a Hold on Akamai (AKAM)
RBC Capital analyst Rishi Jaluria maintained a Hold rating on Akamai (AKAM – Research Report) on January 20 and set a price target of $100.00.
Comerica Incorporated (CMA) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call January 22, 2025 8:00 AM ETCompany ParticipantsKelly Gage - Director, IRCurt Farmer ...